Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and OutcomesKelly L. Bolton, Elli Papaemmanuil, Denise Chen et al.|Clinical Cancer Research|2022Cited by 103
CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium studyEunyoung Kang, Jessica Berger, Christiani Bisinotto et al.|Cancer|2022Cited by 46
Validated biomarker assays confirm that <scp>ARID1A</scp> loss is confounded with <scp>MMR</scp> deficiency, <scp> CD8 <sup>+</sup> TIL </scp> infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomasKarolin Heinze, Yurii B. Shvetsov, Tayyebeh M. Nazeran et al.|The Journal of Pathology|2021Cited by 42
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium studyMartin Köbel, Jaime Lesnock, Eunyoung Kang et al.|The Journal of Pathology Clinical Research|2023Cited by 29
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinomaEun Young Kang, Alexander Hein, Joshua Millstein et al.|Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin|2021Cited by 23